The Sir2 family of protein deacetylases

Current Opinion in Chemical Biology

Volumn 9, Issue 5, 2005, Pages 431-440

  Denu, John M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; NICOTINAMIDE; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN;

APOPTOSIS; CATALYSIS; CELL SURVIVAL; CHEMICAL INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN STRUCTURE; REVIEW; X RAY ANALYSIS; ACETYLATION; CHEMISTRY; ENZYME SPECIFICITY; KINETICS; METABOLISM; PROTEIN CONFORMATION;

ACETYLATION; KINETICS; PROTEIN CONFORMATION; SIRTUINS; SUBSTRATE SPECIFICITY;

EID: 25144496904     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.08.010     Document Type: Review

References (69)

1. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu Rev Biochem 73 2004 417 435
2. D. Moazed Enzymatic activities of Sir2 and chromatin silencing Curr Opin Cell Biol 13 2001 232 238
3. R.A. Frye Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity Biochem Biophys Res Commun 260 1999 273 279
4. R.A. Frye Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochem Biophys Res Commun 273 2000 793 798
5. S.M. Gasser, and M.M. Cockell The molecular biology of the SIR proteins Gene 279 2001 1 16
6. L.N. Rusche, and J. Rine Conversion of a gene-specific repressor to a regional silencer Genes Dev 15 2001 955 967
7. M. Kaeberlein, M. McVey, and L. Guarente The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev 13 1999 2570 2580
8. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230
9. B. Rogina, and S.L. Helfand Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc Natl Acad Sci USA 101 2004 15998 16003
10. B.J. North, and E. Verdin Sirtuins: Sir2-related NAD-dependent protein deacetylases Genome Biol 5 2004 224
11. V.J. Starai, H. Takahashi, J.D. Boeke, and J.C. Escalante-Semerena A link between transcription and intermediary metabolism: a role for Sir2 in the control of acetyl-coenzyme A synthetase Curr Opin Microbiol 7 2004 115 119
12. V.J. Starai, I. Celic, R.N. Cole, J.D. Boeke, and J.C. Escalante-Semerena Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine Science 298 2002 2390 2392 This study demonstrated a clear link between sirtuins and the direct control of metabolic pathways regulated by acetyl-CoA synthetase. This was one of first studies to establish non-histone proteins as target substrates of sirtuins.
13. V.J. Starai, H. Takahashi, J.D. Boeke, and J.C. Escalante-Semerena Short-chain fatty acid activation by acyl-coenzyme A synthetases requires SIR2 protein function in Salmonella enterica and Saccharomyces cerevisiae Genetics 163 2003 545 555
14. H. Vaziri, S.K. Dessain, E. Ng Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente, and R.A. Weinberg hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
15. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
16. E. Langley, M. Pearson, M. Faretta, U.M. Bauer, R.A. Frye, S. Minucci, P.G. Pelicci, and T. Kouzarides Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence EMBO J 21 2002 2383 2396
17. A. Brunet, L.B. Sweeney, J.F. Sturgill, K.F. Chua, P.L. Greer, Y. Lin, H. Tran, S.E. Ross, R. Mostoslavsky, and H.Y. Cohen Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase Science 303 2004 2011 2015
18. M.C. Motta, N. Divecha, M. Lemieux, C. Kamel, D. Chen, W. Gu, Y. Bultsma, M. McBurney, and L. Guarente Mammalian SIRT1 represses forkhead transcription factors Cell 116 2004 551 563
19. H. Daitoku, M. Hatta, H. Matsuzaki, S. Aratani, T. Ohshima, M. Miyagishi, T. Nakajima, and A. Fukamizu Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity Proc Natl Acad Sci USA 101 2004 10042 10047
20. T. Bouras, M. Fu, A.A. Sauve, F. Wang, A.A. Quong, N.D. Perkins, R.T. Hay, W. Gu, and R.G. Pestell SIRT1 deacetylation and repression of P300 involves lysine residues 1020/1024 within the cell-cycle regulatory domain 1 J Biol Chem 280 2005 10264 10276
21. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J 23 2004 2369 2380
22. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118 This work along with that reported in [23], established SIRT1 as a critical regulator of PGC-1α, a coactivator that regulates cellular metabolism. These results implicate SIRT1 in the basic pathways of energy homeostasis, diabetes and lifespan.
23. S. Nemoto, M.M. Fergusson, and T. Finkel SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J Biol Chem 280 2005 16456 16460
24. J. Landry, A. Sutton, S.T. Tafrov, R.C. Heller, J. Stebbins, L. Pillus, and R. Sternglanz The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases Proc Natl Acad Sci USA 97 2000 5807 5811
25. J.S. Smith, C.B. Brachmann, I. Celic, M.A. Kenna, S. Muhammad, V.J. Starai, J.L. Avalos, J.C. Escalante-Semerena, C. Grubmeyer, and C. Wolberger A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family Proc Natl Acad Sci USA 97 2000 6658 6663
26. K.G. Tanner, J. Landry, R. Sternglanz, and J.M. Denu Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose Proc Natl Acad Sci USA 97 2000 14178 14182
27. J.C. Tanny, and D. Moazed Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product Proc Natl Acad Sci USA 98 2001 415 420
28. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
29. A.A. Sauve, I. Celic, J. Avalos, H. Deng, J.D. Boeke, and V.L. Schramm Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions Biochemistry 40 2001 15456 15463
30. M.D. Jackson, and J.M. Denu Structural identification of 2′- and 3′-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta-NAD+-dependent histone/protein deacetylases J Biol Chem 277 2002 18535 18544
31. J.H. Chang, H.C. Kim, K.Y. Hwang, J.W. Lee, S.P. Jackson, S.D. Bell, and Y. Cho Structural basis for the NAD-dependent deacetylase mechanism of Sir2 J Biol Chem 277 2002 34489 34498
32. C.M. Grozinger, and S.L. Schreiber Deacetylase enzymes: biological functions and the use of small-molecule inhibitors Chem Biol 9 2002 3 16
33. + salvage pathway and Sir2 functions in gene silencing and ageing.
34. C.M. Gallo, D.L. Smith Jr., and J.S. Smith Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity Mol Cell Biol 24 2004 1301 1312
35. J.J. Sandmeier, I. Celic, J.D. Boeke, and J.S. Smith Telomeric and rDNA silencing in Saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway Genetics 160 2002 877 889
36. R.M. Anderson, K.J. Bitterman, J.G. Wood, O. Medvedik, and D.A. Sinclair Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae Nature 423 2003 181 185 The authors reported evidence that nicotinamide is a cellular inhibitor of ySir2 and that PNC1, a nicotinamidase of the NAD salvage pathway, controls cellular nicotinamide levels and Sir2 activity.
37. •], demonstrated that NAD biosynthetic enzymes can regulate SIRT1 function in mammalian cells.
38. T. Araki, Y. Sasaki, and J. Milbrandt Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013 In addition to indicating that nuclear NAD biosynthesis can upregulate SIRT1, this work suggested that SIRT1 functions in protecting neuronal cells from injury such as oxidant insult.
39. J.M. Denu Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases Trends Biochem Sci 28 2003 41 48
40. M.T. Borra, F.J. O'Neill, M.D. Jackson, B. Marshall, E. Verdin, K.R. Foltz, and J.M. Denu Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases J Biol Chem 277 2002 12632 12641 The production of O-acetyl-ADP-ribose by sirtuins was shown to be universally conserved among active enzymes from diverse species. Also, this was the first report to show the biological effects of O-acetyl-ADP-ribose by microinjection.
41. L.A. Rafty, M.T. Schmidt, A.L. Perraud, A.M. Scharenberg, and J.M. Denu Analysis of O-acetyl-ADP-ribose as a target for Nudix ADP-ribose hydrolases J Biol Chem 277 2002 47114 47122
42. M.T. Borra, M.R. Langer, J.T. Slama, and J.M. Denu Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases Biochemistry 43 2004 9877 9887 This kinetic study established the complete kinetic mechanism for sirtuin enzymes. Acetyl-peptide substrate analysis provided evidence that the catalytic domains of sirtuins exhibit substrate preferences.
43. J.L. Avalos, I. Celic, S. Muhammad, M.S. Cosgrove, J.D. Boeke, and C. Wolberger Structure of a Sir2 enzyme bound to an acetylated p53 peptide Mol Cell 10 2002 523 535 This binary complex structure was the first to establish the acetyl-peptide binding site within sirtuins.
44. J. Min, J. Landry, R. Sternglanz, and R.M. Xu Crystal structure of a SIR2 homolog-NAD complex Cell 105 2001 269 279
45. J.L. Avalos, K.M. Bever, and C. Wolberger Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme Mol Cell 17 2005 855 868
46. + binding surface, highlighted by nicotinamide bound to the previously described C pocket [44].
47. K. Zhao, R. Harshaw, X. Chai, and R. Marmorstein Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases Proc Natl Acad Sci USA 101 2004 8563 8568 A ternary complex between HST2, a histone acetyl-peptide and an NAD analog provided additional structural evidence for the mechanism of catalysis by sirtuins.
48. A.A. Sauve, and V.L. Schramm SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates Curr Med Chem 11 2004 807 826
49. M.D. Jackson, M.T. Schmidt, N.J. Oppenheimer, and J.M. Denu Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases J Biol Chem 278 2003 50985 50998 This study provided the molecular insight into the mechanisms of catalysis and of nicotinamide inhibition by sirtuins.
50. A.A. Sauve, and V.L. Schramm Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry Biochemistry 42 2003 9249 9256 This study describes the mechanistic basis for nicotinamide inhibition, and suggested the use of nicotinamide analogs as sirtuin activators.
51. J.C. Tanny, G.J. Dowd, J. Huang, H. Hilz, and D. Moazed An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing Cell 99 1999 735 745
52. J.A. Garcia-Salcedo, P. Gijon, D.P. Nolan, P. Tebabi, and E. Pays A chromosomal SIR2 homologue with both histone NAD-dependent ADP- ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei EMBO J 22 2003 5851 5862
53. G. Liszt, E. Ford, M. Kurtev, and L. Guarente Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase J Biol Chem 280 2005 21313 21320
54. K. Zhao, X. Chai, and R. Marmorstein Structure of the yeast Hst2 protein deacetylase in ternary complex with 2′-O-acetyl ADP ribose and histone peptide Structure (Camb) 11 2003 1403 1411
55. G. Blander, J. Olejnik, E. Krzymanska-Olejnik, T. McDonagh, M. Haigis, M.B. Yaffe, and L. Guarente SIRT1 shows no substrate specificity in vitro J Biol Chem 280 2005 9780 9785
56. M.T. Schmidt, B.C. Smith, M.D. Jackson, and J.M. Denu Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation J Biol Chem 279 2004 40122 40129
57. J. Landry, J.T. Slama, and R. Sternglanz Role of NAD(+) in the deacetylase activity of the SIR2-like proteins Biochem Biophys Res Commun 278 2000 685 690
58. K.J. Bitterman, R.M. Anderson, H.Y. Cohen, M. Latorre-Esteves, and D.A. Sinclair Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1 J Biol Chem 277 2002 45099 45107
59. A.A. Sauve, R.D. Moir, V.L. Schramm, and I.M. Willis Chemical activation of sir2- dependent silencing by relief of nicotinamide inhibition Mol Cell 17 2005 595 601 These authors used isonicotinamide as an activator of ySir2 in vitro and in vivo. This work suggests the possibility of developing sirtuin activators that compete for the nicotinamide binding site and relieve endogenous nicotinamide inhibition.
60. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, and L.L. Zhang Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
61. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and D. Sinclair Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689 The authors of this study and that of [60] report the anti-aging effects of resveratrol and suggest that Sir2 proteins are the direct in vivo targets of resveratrol, leading to activation of protein deacetylation.
62. •] demonstrated that the apparent in vitro activation of sirtuins by resveratrol results from the use of artificial fluorescent peptides. In yeast, these authors report no Sir2 activation by resveratrol.
63. M.T. Borra, B.C. Smith, and J.M. Denu Mechanism of human SIRT1 activation by resveratrol J Biol Chem 280 2005 17187 17195 This report provided the mechanistic basis for the apparent activation of SIRT1 by resveratrol, when a variety of both native and fluorescently labeled peptides are employed as substrates.
64. C.M. Grozinger, E.D. Chao, H.E. Blackwell, D. Moazed, and S.L. Schreiber Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening J Biol Chem 276 2001 38837 38843 Using a chemical genetics approach, these authors identified the molecule sirtinol as an inhibitor of ySir2.
65. A. Bedalov, T. Gatbonton, W.P. Irvine, D.E. Gottschling, and J.A. Simon Identification of a small molecule inhibitor of Sir2p Proc Natl Acad Sci USA 98 2001 15113 15118 Using a chemical genetics approach, splitomicin was discovered as an inhibitor of sirtuins.
66. J. Posakony, M. Hirao, S. Stevens, J.A. Simon, and A. Bedalov Inhibitors of Sir2: evaluation of splitomicin analogues J Med Chem 47 2004 2635 2644
67. +-dependent deacetylases using phenotypic screens in yeast J Biol Chem 278 2003 52773 52782
68. A.J. Tervo, S. Kyrylenko, P. Niskanen, A. Salminen, J. Leppanen, T.H. Nyronen, T. Jarvinen, and A. Poso An in silico approach to discovering novel inhibitors of human sirtuin type 2 J Med Chem 47 2004 6292 6298
69. M. Fulco, R.L. Schiltz, S. Iezzi, M.T. King, P. Zhao, Y. Kashiwaya, E. Hoffman, R.L. Veech, and V. Sartorelli Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state Mol Cell 12 2003 51 62